Henderson Jane — SEC Form 4 filings
SEC reporting owner CIK 1422304. 23 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2024-06-06 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 14 filings — 36,500 shares, $2,524,738 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 4,080 shares @ $75.20 ($306,816) in Apogee Therapeutics, Inc., filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 16 | — | 23 legs · 33,500 sh · $2,382,367 | 7 |
| Akero Therapeutics, Inc. (AKRO) | Director | 4 | — | 1 leg · 3,000 sh · $142,371 | 11 |
| CARGO Therapeutics, Inc. (CRGX) | Director | 3 | — | — | 4 |
Form 4 filings — Henderson Jane
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Disposition to issuer (D): 158,371 · Disposition to issuer (D): 175,345 (derivative) · Disposition to issuer (D): 124,962 (derivative) · Disposition to issuer (D): 83,690 (derivative) | EDGAR |
| 2026-07-24 | 4 | Apogee Therapeutics, Inc. (APGE) | Gift (G): 15,000 @ $0 | EDGAR |
| 2026-05-04 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 811 @ $81.02 · Sale (S): 900 @ $82.60 · Sale (S): 289 @ $83.16 | EDGAR |
| 2026-04-17 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,000 @ $90 | EDGAR |
| 2026-04-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 900 @ $84.46 · Sale (S): 1,100 @ $85.46 | EDGAR |
| 2026-03-27 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,000 @ $85 | EDGAR |
| 2026-03-04 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 300 @ $68.27 · Sale (S): 300 @ $69.43 · Sale (S): 994 @ $70.45 · Sale (S): 406 @ $71.66 | EDGAR |
| 2026-02-04 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 792 @ $65.21 · Sale (S): 1,108 @ $66.15 · Sale (S): 100 @ $66.89 | EDGAR |
| 2026-01-06 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 1,920 @ $74.13 · Sale (S): 4,080 @ $75.20 · Sale (S): 2,000 @ $80 · Grant/award (A): 83,690 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 1,500 @ $80 | EDGAR |
| 2025-12-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Disposition to issuer (D): 9,398 · Disposition to issuer (D): 26,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 13,000 (derivative) · Disposition to issuer (D): 13,000 (derivative) · +1 more | EDGAR |
| 2025-12-05 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 1,500 @ $75 | EDGAR |
| 2025-11-28 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 1,500 @ $70 | EDGAR |
| 2025-11-14 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,000 @ $65 | EDGAR |
| 2025-11-13 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 1,000 @ $60 | EDGAR |
| 2025-08-19 | 4 | CARGO Therapeutics, Inc. (CRGX) | Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2025-08-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 3,000 @ $7.01 · Sale (S): 3,000 @ $47.46 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 9,398 @ $0 | EDGAR |
| 2024-12-11 | 4 | Apogee Therapeutics, Inc. (APGE) | Grant/award (A): 124,962 (derivative) @ $0 | EDGAR |
| 2024-08-23 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 6,000 @ $48.26 | EDGAR |
| 2024-06-11 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 19,785 (derivative) @ $0 · Grant/award (A): 39,402 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1422304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →